Aurox Ltd is a leading company in the design and manufacture of innovative optical imaging equipment. Established in 2004, it aims to commercialize and build upon pioneering work from the Scanning Optical Microscopy Group at the University of Oxford, Department of Engineering Science. Aurox has garnered recognition in the form of multiple business and technology awards, including the Queen's Award for Enterprise, the Institute of Physics (IOP) Innovation award, and the R&D100 award.
The company's flagship product, the Clarity Laser Free Confocal (LFC) unit, stands out as a groundbreaking achievement in the field of confocal microscopy. This product, which is based on the award-winning Aurox SD62, has been previously sold by Andor as the Revolution DSD2 and by Zeiss as the Vivatome. The Clarity LFC introduces a revolutionary design that enables affordable confocal microscopy, making high-quality 3D images accessible in real-time. Aurox has also been working on developing a core imaging technology that underpins a new range of confocal microscopy systems, addressing specific market needs in applications such as live cell imaging, high throughput screening, and materials inspection.
The company operates in the Manufacturing and Marketing industries, with a focus on expanding the accessibility of advanced imaging technologies. Notably, Aurox has not disclosed its last investment details or the involved investors. However, with its strong track record of innovation and recognition in the industry, Aurox Ltd presents an intriguing prospect for potential venture capitalists seeking to invest in cutting-edge imaging technology advancements.
There is no investment information
No recent news or press coverage available for Aurox Ltd.